It targets three incretin-related receptors simultaneously the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor
Furthermore, it slows down the stomach's emptying, which may help with weight loss and contribute to a fullness sensation
Delivery systems using microneedling technologies are being developed and tested to make GLP-1 patches a reality in the near future for people with needle anxiety
In the sections ahead, we explain how our top picks performed in these areas and where certain products stood out
For instance, Billings cited research on cancer treatments showing that people may consider delaying future treatment or stopping potentially lifesaving treatment due to nausea
Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists Use in Elderly People With ObesityA Meta-Analysis